What's in Children's Oncology Group's pipeline?

Children's Oncology Group has 12 drugs in our index: 0 marketed, 0 filed, 4 in Phase 3, 2 in Phase 2, 6 in Phase 1.

Which companies overlap with Children's Oncology Group's portfolio?

Top competitors by shared drug class: Ain Shams University, Hospital General de Mexico.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/children-s-oncology-group.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Children's Oncology Group — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Children's Oncology Group pipeline: 0 marketed, 0 filed, 4 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 4 Phase 3 2 Phase 2 6 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Area
in vitro sensitivity-directed chemotherapy	in vitro sensitivity-directed chemotherapy	phase 3		Oncology
supersaturated calcium phosphate rinse	supersaturated calcium phosphate rinse	phase 3
Lactobacillus plantarum strain 299	Lactobacillus plantarum strain 299	phase 3	Live biotherapeutic product / Probiotic	Oncology / Immunology
Lactobacillus plantarum strain 299v	Lactobacillus plantarum strain 299v	phase 3	Live biotherapeutic product; probiotic	Oncology; Immunology

Therapeutic area mix

Oncology · 2
Oncology / Immunology · 1
Oncology; Immunology · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ain Shams University · 1 shared drug class
Hospital General de Mexico · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Children's Oncology Group:

Cite this brief

Drug Landscape (2026). Children's Oncology Group — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/children-s-oncology-group. Accessed 2026-05-16.